Diabetech® Announces GlucoDYNAMIX™; Real-Time Intensive Management Protocols for Diabetes

Share Article

Introducing a major step forward in proactive healthcare with a system that supports a real-time virtual-loop for intelligent patient data collection, analysis and intervention on behalf of the medical team.

Coinciding with the opening of the 64th Annual American Diabetes Association’s Scientific Session, Diabetech announces the GlucoDYNAMIX System, a technological breakthrough that closes the loop between patients with diabetes and their medical team for improved outcomes.

“Diabetech is the only company in the world to produce a real-time go-anywhere technology for diabetes management that’s invisible – it doesn’t require a handheld computer, cable connections or learning a new computer program. This end-to-end, automated system is breaking new ground now as we begin the development of several Intensive Management Protocols (IMPs) – packages of finely tuned reports, reminders and alerts that streamline the flow of information to various members of the diabetes team. These pre-designed clinical management modules take time and complexity out while guiding the patient to better blood sugar control and in a safer environment,” says Kevin McMahon, President of Diabetech. “Finally, a diabetes management technology that addresses the specific information needs associated with managing the newly diagnosed, those starting on an insulin pump and other high risk scenarios while always taking into account the individual needs of each patient and his/her team.”

GlucoDYNAMIX IMPs are made possible by Diabetech’s proprietary GlucoMON™ wireless device that is embedded in the case of the patient’s glucose meter. The GlucoMON takes the blood-glucose data from the meter each time a patient tests and wirelessly sends the data to the GlucoDYNAMIX system. Then, built-in intelligence distributes information to the appropriate caregiver at the appropriate time, and in the appropriate format. “Each caregiver is in control of when and how they access the patient’s information. IMPs ensure that no one gets too much information or in a format they can’t use,” says McMahon. Stephen Ponder, an Endocrinologist and Certified Diabetes Educator calls Diabetech’s method for collecting and distributing patient data, “Ridiculously easy.”

Diabetech designs the IMPs in collaboration with people with diabetes, diabetes educators, endocrinologists, and registered nurses many of whom are members of Diabetech’s Clinical Advisory Board. The real difference is having access to real-time patient data to analyze, look for trends and find exceptions to high-risk thresholds in real-time. Within seconds, GlucoDYNAMIX closes the loop.

IMPs will allow traditional diabetes education and training to have a significantly greater impact with only the least amount of effort. Having reliable access to accurate and up to the minute patient information will help the patient team to make better decisions.

“Documented improvements in patient health and cost savings due to the proactive nature of GlucoDYNAMIX IMPs will help to align reimbursement with the high cost of managing diabetes,” says McMahon. "The trend in Managed Care is toward preventative medicine. With better health and fewer emergency room visits, we all win - especially the patient."

Learn more about the GlucoDYNAMIX System at http://www.diabetech.net. Inquiries or requests for a copy of the white paper entitled: “The Real-time Virtual Loop: Collection through Intervention” may be directed to Hilary Hale, Vice President of Corporate Communications, at hilary@diabetech.net.

About Diabetech:

Diabetech is a Dallas, Texas based biomedical technology service provider helping people achieve improved outcomes within the GlucoDYNAMIX proactive diabetes management care system. This wholly managed service is available to connect the patient’s extended management team in order to intelligently share information, analyze patient data and proactively intervene. http://www.diabetech.net.


Share article on social media or email:

View article via:

Pdf Print

Contact Author